FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD) today announced the appointment of David H. Bergstrom, Ph.D. as Chief Operating Officer. Dr. Bergstrom joins NovaDel from Cardinal Health, Inc., where he most recently served as Senior Vice President and General Manager for Cardinal’s Pharmaceutical Development business.
